CASP3 and acute myeloid leukemia: To further confirm that STM2457 enhances venetoclax-induced apoptosis in AML, we analyzed apoptosis-related proteins, including PARP and cleaved Caspase-3 by Western blotting, which demonstrated increased cleavage of PARP and Caspase-3 in the combination treatment group (Fig. 2H–K).